Usefulness of Combining Complement Factor H and C-Reactive Protein Genetic Profiles for Predicting Myocardial Infarction (from the Rotterdam Study)

American Journal of Cardiology

Volumn 100, Issue 4, 2007, Pages 646-648

  Kardys, Isabella ^a   de Maat, Moniek P M ^a   Klaver, Caroline C W ^a,b   Despriet, Dominiek D G ^a,b   Uitterlinden, André G ^a   Hofman, Albert ^a   de Jong, Paulus T V M ^a,b,c   Witteman, Jacqueline C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT FACTOR H;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HAZARD RATIO; HEART INFARCTION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALLELES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMPLEMENT FACTOR H; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34547693329     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.079     Document Type: Article

References (17)

1. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., and Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41 (2004) 355-367
2. Oksjoki R., Jarva H., Kovanen P.T., Laine P., Meri S., and Pentikainen M.O. Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation. Arterioscler Thromb Vasc Biol 23 (2003) 630-636
3. Fearon D.T. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci U S A 75 (1978) 1971-1975
4. Mold C., Kingzette M., and Gewurz H. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. J Immunol 133 (1984) 882-885
5. Kardys I., Klaver C.C., Despriet D.D., Bergen A.A., Uitterlinden A.G., Hofman A., Oostra B.A., Van Duijn C.M., de Jong P.T., and Witteman J.C. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol 47 (2006) 1568-1575
6. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., Lowe G.D., Pepys M.B., and Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
7. Carlson C.S., Aldred S.F., Lee P.K., Tracy R.P., Schwartz S.M., Rieder M., Liu K., Williams O.D., Iribarren C., Lewis E.C., et al. Polymorphisms within the c-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77 (2005) 64-77
8. Miller D.T., Zee R.Y., Suk Danik J., Kozlowski P., Chasman D.I., Lazarus R., Cook N.R., Ridker P.M., and Kwiatkowski D.J. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69 (2005) 623-638
9. Kardys I., de Maat M.P., Uitterlinden A.G., Hofman A., and Witteman J.C. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J 27 (2006) 1331-1337
10. Lange L.A., Carlson C.S., Hindorff L.A., Lange E.M., Walston J., Durda J.P., Cushman M., Bis J.C., Zeng D., Lin D., et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296 (2006) 2703-2711
11. Hofman A., Grobbee D.E., de Jong P.T., and van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7 (1991) 403-422
12. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision (1992), WHO, Geneva, Switzerland
13. D.Nickerson Seattle SNPs: NHLBI program for genomic applications. Seattle: UW-FHCRC. Available at http://pga.gs.washington.edu. Accessed February 16, 2007.
14. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
15. Despriet D.D., Klaver C.C., Witteman J.C., Bergen A.A., Kardys I., de Maat M.P., Boekhoorn S.S., Vingerling J.R., Hofman A., Oostra B.A., Uitterlinden A.G., Stijnen T., et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 296 (2006) 301-309
16. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102 (2005) 7227-7232
17. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., Sangiovanni J.P., Mane S.M., Mayne S.T., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389